DS
ZVSAW

David Shaw’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

David Shaw’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-262,499
Closed -$31K – 5410
2022
Q3 		$31K Hold
262,499
– – ﹤0.01% 4757
2022
Q2 		$26K Buy
262,499
+175,000
+200% +$30.4K ﹤0.01% 4966
2022
Q1 		$15K Buy
+87,499
New +$17.7K ﹤0.01% 5376

David Shaw's ZVSAW Position: Q4 2022 in Review

David Shaw sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 262,499 shares — an estimated $31K sold.

David Shaw first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $31K in Q3 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • David Shaw reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 262,499 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $31K.
  • David Shaw first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
  • David Shaw's ZyVersa Therapeutics, Inc. Warrants position peaked at $31K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.